Greylin Investment Mangement Has Lifted Pfizer (PFE) Stake; New York & Company (NWY)’s Sentiment Is 0.64

August 3, 2017 - By Linda Rogers

New York & Company, Inc. is a specialty retailer of women’s fashion apparel and accessories. The company has market cap of $100.89 million. The Company’s branded New York & Company merchandise is sold through its national network of retail stores and online at www.nyandcompany.com. It currently has negative earnings. It operates approximately 490 stores, including over 80 outlet stores in over 40 states.

Greylin Investment Mangement Inc increased Pfizer Inc (PFE) stake by 37.56% reported in 2016Q4 SEC filing. Greylin Investment Mangement Inc acquired 12,500 shares as Pfizer Inc (PFE)’s stock declined 3.45%. The Greylin Investment Mangement Inc holds 45,776 shares with $1.49M value, up from 33,276 last quarter. Pfizer Inc now has $199.68B valuation. The stock rose 1.91% or $0.63 reaching $33.53 per share. About 4.18M shares traded. Pfizer Inc. (NYSE:PFE) has declined 2.76% since August 3, 2016 and is downtrending. It has underperformed by 19.46% the S&P500.

Since February 27, 2017, it had 0 buys, and 5 sales for $5.16 million activity. $153,855 worth of stock was sold by JOHNSON RADY A on Friday, March 10. 20,000 shares were sold by LANKLER DOUGLAS M, worth $693,200 on Thursday, March 2. 30,970 shares valued at $1.07M were sold by Dolsten Mikael on Wednesday, March 1. Another trade for 36,000 shares valued at $1.23 million was made by HILL CHARLES H on Thursday, March 9.

Greylin Investment Mangement Inc decreased Coach Inc (NYSE:COH) stake by 8,680 shares to 730,570 valued at $25.59M in 2016Q4. It also reduced Joy Global Inc (NYSE:JOY) stake by 43,005 shares and now owns 173,845 shares. Us Bancorp Del (NYSE:USB) was reduced too.

Investors sentiment decreased to 1.13 in 2016 Q4. Its down 0.05, from 1.18 in 2016Q3. It dived, as 60 investors sold PFE shares while 672 reduced holdings. 115 funds opened positions while 711 raised stakes. 4.12 billion shares or 1.11% more from 4.08 billion shares in 2016Q3 were reported. Df Dent And Com holds 32,202 shares. Mirae Asset Global Invs Ltd holds 0.89% or 1.23 million shares in its portfolio. Fairfax Fincl Hldg Ltd Can invested in 0.58% or 210,000 shares. Moreover, Chase Investment Counsel Corp has 0.1% invested in Pfizer Inc. (NYSE:PFE). Hodges Management, Texas-based fund reported 6,189 shares. Private Wealth owns 11,805 shares. Royal Bancshares Of Scotland Gru Public Limited Liability Company has invested 0.09% in Pfizer Inc. (NYSE:PFE). Cullen Frost Bankers Inc holds 0.34% or 304,653 shares. Janney Capital Mngmt Limited, a Pennsylvania-based fund reported 645,952 shares. Nomura Holdg stated it has 0.13% of its portfolio in Pfizer Inc. (NYSE:PFE). Nadler accumulated 33,507 shares or 0.4% of the stock. 292,895 are held by Chesley Taft And Ltd Com. Utd Cap Financial Advisers Ltd Company holds 963,890 shares. Century Cos Inc accumulated 0.72% or 20.44M shares. Symphony Asset Mgmt Llc has invested 0.31% in Pfizer Inc. (NYSE:PFE).

Among 20 analysts covering Pfizer (NYSE:PFE), 6 have Buy rating, 1 Sell and 13 Hold. Therefore 30% are positive. Pfizer has $51 highest and $3300 lowest target. $38.51’s average target is 14.85% above currents $33.53 stock price. Pfizer had 50 analyst reports since July 29, 2015 according to SRatingsIntel. As per Tuesday, May 16, the company rating was downgraded by Citigroup. Barclays Capital initiated the stock with “Equal-Weight” rating in Tuesday, December 1 report. Piper Jaffray maintained Pfizer Inc. (NYSE:PFE) rating on Friday, August 28. Piper Jaffray has “Overweight” rating and $48 target. The firm has “Neutral” rating given on Friday, March 24 by Societe Generale. The rating was maintained by Piper Jaffray with “Buy” on Friday, August 14. Cowen & Co upgraded Pfizer Inc. (NYSE:PFE) on Tuesday, October 20 to “Outperform” rating. Leerink Swann maintained the shares of PFE in report on Monday, May 2 with “Market Perform” rating. The firm has “Overweight” rating given on Thursday, April 7 by JP Morgan. The stock of Pfizer Inc. (NYSE:PFE) has “Buy” rating given on Wednesday, October 28 by Deutsche Bank. The company was downgraded on Thursday, July 20 by Credit Suisse.

It is down 49.15% since August 3, 2016 and is downtrending. It has underperformed by 65.85% the S&P500.